Ferring launches Guts4life, an interactive online resource for people with inflammatory bowel disease
-Ferring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (www.guts4life.com), a new interactive website with information…
New study suggests desmopressin melt improves sleep patterns and psychological functioning of bedwetting children
-New data has shown that treatment with melt-in-the-mouth desmopressin (MINIRIN® Melt)* improved sleep patterns and psychological functioning…
Real-world patient survey data shows negative impact of nocturia
-New patient survey data presented today at the European Association of Urology (EAU 14) congress, showed that nocturia…
MSD, Ferring Pharmaceuticals and the World Health Organization – Working Together to Prevent Excessive Bleeding in Women after Childbirth
-Ferring Pharmaceuticals and MSD, known as Merck in the United States and Canada, today announced their collaboration with the World Health…
New paper indicates a potential fifty-percent reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease when treated with FIRMAGON® (degarelix) compared to LHRH agonists
-A paper published today in European Urology, the official journal of the European Association of Urology, indicates that the gonadotropin…
Archives Press release 2014
Archives Press release 2014